← All organizations

Immunomic Therapeutics, Inc.

For profitWebsite ↗

Also known as: Immunomic Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 21, 2023

Timeline

2000s

Jun 1, 2005
Immunomic Therapeutics, Inc.— Founded

Drugs by trial phase (6 distinct, 8 trials)

Phase 2 (1 own, 0 via acquisition)

asp4070

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT05698199Lead sponsorPhase 1Aug 21, 2023
NCT05422781Lead sponsorPhase 1Jun 13, 2022
NCT04963413CollaboratorPhase 1Dec 31, 2021
NCT03101267CollaboratorPhase 2Apr 13, 2017
NCT02469688CollaboratorPhase 1Jun 1, 2015
NCT02146781Lead sponsorPhase 1Jun 1, 2014
NCT01966224Lead sponsorPhase 1Sep 1, 2013
NCT01707069Lead sponsorPhase 1Oct 1, 2012

Details

Founded: Lancaster, PA, US Jun 1, 2005
Last known activity: Aug 21, 2023